These foods will not interfere with Biktarvy absorption. There are no food restrictions with Biktarvy--only restrictions on specific antacids and supplements that contain divalent cations. I would not ask him about this, as it will only confuse or worry him. Biktarvy should be easy for patients to take; there's no need to complicate things unnecessarily!
Original Message:
Sent: 02-18-2026 13:29
From: Victoria Cesar
Subject: Treatment Experienced, HIV+, Mutation Inquiry
Hello Dr. Psaros. Thank you for your reply. At this time, I do not believe he is taking any of the noted foods above. I will check with him at his upcoming appointment. Would these foods decrease absorption of Biktarvy? If so, how long between these foods and Biktarvy administration should the patient wait? Thank you!
------------------------------
Victoria Cesar
Titusville FL
Original Message:
Sent: 02-18-2026 00:35
From: Steven Psaros
Subject: Treatment Experienced, HIV+, Mutation Inquiry
I'd like to expand on Dr. Gallant's comments regarding polyvalent cations.
Is this patient taking his meds with dairy milk, fortified plant milk, fortified orange juice, nutritional drinks like Ensure, or even electrolyte drinks or preworkout powder mixes while fasted?
------------------------------
Steven Psaros
Shelby Township MI
Original Message:
Sent: 02-17-2026 12:01
From: Victoria Cesar
Subject: Treatment Experienced, HIV+, Mutation Inquiry
Hello everyone,
Hoping for input on a case that I have been working on recently.
HIV MALE 76YO
On Biktarvy + Pilfelto, reports taking oral medications daily but based on recent genosure results, concerned for non compliance
Has had the following HIV RNA VL: 09/2025 - 91 , 10/2025 - 111 , 01/2026 171
Due to rising VL without missed doses (as reported by the patient), ran genosure archive showing resistance to Raltegravir
RT --> V60I,R83K, Q102K, I135T, C162S,R277K, T286A, M357V, K358R,, T386I, A400T
IN -->S39C, V72I, L101I, V113I, T124A, T125A, Y143Y/H, D167E, K173R, I182V, V201I, V234L, D278E
Previous genotyping from Quest 03/2025 shows: M184V + I13V and V771
M184V not appreciated on Genosure Archive from Labcorp in 01/2026
After researching mutations listed above, it appears that the Biktarvy+Pilfeltro regimen should be keeping the patient suppressed. Is there anything I may be missing
------------------------------
Victoria Cesar MSN, APRN, FNP-C, AAHIVS
Titusville FL
------------------------------